Authors

Michael McDermott, Miami Neuroscience InstituteFollow

CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases

Publication Date

1-28-2023

Content Type

Article

PubMed ID:

36915611

Additional Authors:

Additional authors and institutional affiliations

Citation

Morshed, R. A., Nguyen, M. P., Cummins, D. D., Saggi, S., Young, J. S., Haddad, A. F., Goldschmidt, E., Chang, E. F., McDermott, M. W., Berger, M. S., Theodosopoulos, P. V., Hervey-Jumper, S. L., Daras, M., & Aghi, M. K. (2023). CDKN2A/B co-deletion is associated with increased risk of local and distant intracranial recurrence after surgical resection of brain metastases. Neuro-oncology advances, 5(1), vdad007. https://doi.org/10.1093/noajnl/vdad007